Search Results 161-170 of 17589 for tsh

  1. NRG-GY012 “A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5356 (Capivasertib) in Women with Recurrent, Persistent or Metastatic Endometrial Cancer. A Multi-Arm Trial for Women with Recurrent or Persistent Endometrial Cancer” - Mayo Clinic

    Adequately controlled thyroid function, with no symptoms of thyroid dysfunction and thyroid-stimulating hormone (TSH) within normal limits. Exclusion ...

  2. Thyroid (oral route) - Side effects & dosage - Mayo Clinic

    Thyroid is also used in some medical tests to help diagnose problems with the thyroid gland. This medicine is available only with your doctor's prescription.

  3. A Study to Investigate the Safety and Effectiveness of FE 999049 in Controlled Ovarian Stimulation in Women Aged 35-42 Years Old - Mayo Clinic

    Any abnormal finding of clinical chemistry, hematology, thyroid-stimulating hormone (TSH) or prolactin, or vital signs at screening, which is judged clinically ...

  4. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  5. Lymphocytosis (high lymphocyte count) Causes - Mayo Clinic

    Causes · Infection, including bacterial, viral or other type of infection. · Cancer of the blood or lymphatic system. · An autoimmune disease causing ongoing, ...

  6. PACTAID App In Adults With Type 1 Diabetes To Help Manage Exercise - Mayo Clinic

    ... TSH at the time of screening * Severe hypoglycemia or DKA in last 3 months. * Baseline exercise status-those already doing vigorous exercise such as 1 hour ...

  7. https://www.mayoclinic.org/spanish_patient_consumer_video.xml

  8. A Study of BHV-3241 in Subjects with Multiple System Atrophy - Mayo Clinic

    Abnormal free T4 levels and TSH > 10 mIU/L (despite treatment) at Screening, confirmed by repeat. Total bilirubin, alanine aminotransferase (ALT) or ...

  9. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

  10. Metabolic and Physiologic Responses to Hormone Therapy in Transgender and Gender Diverse People - Mayo Clinic

    * Uncontrolled thyroid disease (TSH undetectable or \>10 mlU/L); testing required within three months prior to admission for subjects with a goiter ...